Cancer Microbiome Sequencing Market - Global Forecast 2026-2032

The Cancer Microbiome Sequencing Market is at a pivotal stage, as recent platform advancements and accelerating clinical adoption reshape oncology research and patient management. Stakeholders actively recalibrate their strategies to capitalize on operational shifts and inject greater value into translational efforts.

Market Snapshot: Cancer Microbiome Sequencing Market Outlook

Between 2025 and 2026, the Cancer Microbiome Sequencing Market expanded from USD 897.54 million to USD 992.40 million, demonstrating robust growth with a projected CAGR of 10.85%. The market is forecast to achieve USD 1.84 billion by 2032. Expansion is propelled by demand for precision diagnostics, improved integration of sequencing technologies, and their influence on procurement decisions, trial design, and innovation in research and development across global regions.

Scope & Segmentation

Technology Types: Key methodologies include 16S rRNA sequencing, shotgun metagenomics, and whole genome sequencing, each offering varying levels of analytical detail for both research and clinical workflows.
Clinical Indications: Primarily addresses breast, colorectal, and lung cancers, where microbiome data inform therapeutic decisions and risk stratification strategies.
Sample Matrices: Encompasses blood, fecal, and tissue sampling, each presenting unique challenges for sample processing, preservation, and accurate downstream data analysis.
Workflow Stages: Covers sample collection, preservation, sequencing, and interpretation phases, increasingly emphasizing reproducibility and interoperability across analytical processes.
End-User Profiles: Engages a spectrum of stakeholders including hospitals and clinics, pharmaceutical and biotechnology enterprises, and research institutions, each with distinct procurement timelines and integration requirements.
Regional Coverage: Market is segmented across Americas, Europe, Middle East & Africa, and Asia-Pacific, with notable variations in infrastructure maturity, policy frameworks, and logistical dynamics.

Key Takeaways: Strategic Insights for Senior Decision-Makers

Sequencing workflows have transitioned to modular designs, enhancing flexibility and standardization across multiple sample matrices while minimizing technical variability in multicenter collaborations.
Comprehensive bioinformatics frameworks are central to interpreting complex sequencing outputs, enabling the identification of actionable biomarkers and fostering multi-site comparative studies.
Ongoing advancements in sequencing technologies allow organizations to balance scale and analytical depth, supporting both broad screening initiatives and detailed mechanistic investigations in oncology pathways.
Stakeholders now embed microbiome sequencing into early clinical trial phases to detect predictive biomarkers and streamline patient segmentation, strengthening research robustness.
Regional differences in supply chain resilience, manufacturing capacity, and regulatory structures directly affect decisions about market entry, partnership choices, and operational footprints.

Tariff Impact: Navigating Supply-Chain and Operational Constraints

Impending tariff policy changes in the United States are compelling companies to reassess supply-chain strategies and procurement agility. Adjustments affecting imported reagents, instruments, and consumables may lead to shifts in operational costs, requiring diversification of supply partners. While larger manufacturers can use contractual tools to manage short-term fluctuations, smaller suppliers may encounter margin challenges and the need to renegotiate contracts. Scenario planning and compliance-focused procurement models help institutions maintain uninterrupted sequencing workflows and mitigate unforeseen risks.

Methodology & Data Sources

This analysis integrates structured interviews with laboratory, clinical, and procurement leaders, leveraging systematic reviews of technical publications and public reports on sequencing platforms. Data integrity is maintained through triangulation and scenario-based modeling, ensuring findings are actionable for varying market, clinical, and research settings.

Why This Report Matters

Offers a unified perspective on technology, operations, and regulation—informing capital allocation decisions and long-term strategic planning for cancer microbiome sequencing.
Supports targeted investment across analytics, infrastructure, and collaborative ventures to drive forward clinical adoption and improve patient outcomes.
Equips organizations to anticipate supply-chain challenges, align research practices for reproducibility, and identify effective expansion opportunities into new regions.

Conclusion

The Cancer Microbiome Sequencing Market is progressing toward deeper integration in oncology and life sciences. Decision-makers who adapt technology and operational strategies to shifting regional and regulatory landscapes will be best positioned for sustainable growth and clinical impact.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Cancer Microbiome Sequencing Market, by Technology

8.1. 16S Rrna Sequencing
8.2. Shotgun Metagenomic Sequencing
8.3. Whole Genome Sequencing

9. Cancer Microbiome Sequencing Market, by Workflow

9.1. Analytical
9.1.1. Illumina Sequencing
9.1.2. Oxford Nanopore Sequencing
9.1.3. Pacbio Sequencing
9.2. Bioinformatics
9.2.1. Functional Analysis Tools
9.2.2. Statistical Analysis Tools
9.2.3. Taxonomic Profiling Tools
9.3. Pre Analytical

10. Cancer Microbiome Sequencing Market, by Sample Type

10.1. Blood Samples
10.2. Fecal Samples
10.3. Tissue Samples

11. Cancer Microbiome Sequencing Market, by Application

11.1. Breast Cancer
11.2. Colorectal Cancer
11.3. Lung Cancer

12. Cancer Microbiome Sequencing Market, by End User

12.1. Hospitals And Clinics
12.2. Pharmaceutical And Biotechnology Companies
12.3. Research Institutes

13. Cancer Microbiome Sequencing Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Cancer Microbiome Sequencing Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Cancer Microbiome Sequencing Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Cancer Microbiome Sequencing Market
17. China Cancer Microbiome Sequencing Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Agilent Technologies, Inc.
18.7. AstraZeneca PLC
18.8. Athos Therapeutics Inc.
18.9. BGI Genomics Co., Ltd.
18.10. Bio-Rad Laboratories, Inc.
18.11. Bristol-Myers Squibb
18.12. CosmosID
18.13. Creative Biolabs
18.14. Danaher Corporation
18.15. Eurofins Scientific SE
18.16. Evelo Biosciences
18.17. EzBiome
18.18. F. Hoffmann-La Roche AG
18.19. Ferring Pharmaceuticals
18.20. Illumina, Inc.
18.21. LC Sciences
18.22. Merck KGaA
18.23. Metagen Therapeutics
18.24. MV BioTherapeutics SA
18.25. Norgen Biotek Corp.
18.26. Novogene Co, Ltd.
18.27. Oxford Nanopore Technologies Ltd.
18.28. Pacific Biosciences of California, Inc.
18.29. QIAGEN N.V.
18.30. Roche Holding AG
18.31. Thermo Fisher Scientific Inc.
18.32. Vedanta Biosciences.
18.33. Viome Life Sciences, Inc.

List of Figures

FIGURE 1. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CANCER MICROBIOME SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CANCER MICROBIOME SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ILLUMINA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ILLUMINA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PACBIO SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PACBIO SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PACBIO SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FUNCTIONAL ANALYSIS TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FUNCTIONAL ANALYSIS TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FUNCTIONAL ANALYSIS TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY STATISTICAL ANALYSIS TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY STATISTICAL ANALYSIS TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY STATISTICAL ANALYSIS TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TAXONOMIC PROFILING TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TAXONOMIC PROFILING TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TAXONOMIC PROFILING TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PRE ANALYTICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PRE ANALYTICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PRE ANALYTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FECAL SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FECAL SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY FECAL SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TISSUE SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TISSUE SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. EUROPE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 107. EUROPE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 108. EUROPE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 109. EUROPE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 110. EUROPE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 124. AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 125. AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 126. AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 127. AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. AFRICA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. ASEAN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. ASEAN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. ASEAN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 141. ASEAN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 142. ASEAN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 143. ASEAN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 144. ASEAN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 145. ASEAN CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. GCC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GCC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 148. GCC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 149. GCC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 150. GCC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 151. GCC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 152. GCC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. GCC CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. BRICS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. BRICS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. BRICS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 165. BRICS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 166. BRICS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 167. BRICS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 168. BRICS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. BRICS CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. G7 CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. G7 CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. G7 CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 173. G7 CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 174. G7 CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 175. G7 CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 176. G7 CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. G7 CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. NATO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. NATO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. NATO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 181. NATO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 182. NATO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 183. NATO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 184. NATO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. NATO CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL CANCER MICROBIOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. CHINA CANCER MICROBIOME SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 196. CHINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. CHINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
TABLE 198. CHINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY ANALYTICAL, 2018-2032 (USD MILLION)
TABLE 199. CHINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY BIOINFORMATICS, 2018-2032 (USD MILLION)
TABLE 200. CHINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 201. CHINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. CHINA CANCER MICROBIOME SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cancer Microbiome Sequencing market report include:

Abbott Laboratories
Agilent Technologies, Inc.
AstraZeneca PLC
Athos Therapeutics Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bristol-Myers Squibb
CosmosID
Creative Biolabs
Danaher Corporation
Eurofins Scientific SE
Evelo Biosciences
EzBiome
F. Hoffmann-La Roche AG
Ferring Pharmaceuticals
Illumina, Inc.
LC Sciences
Merck KGaA
Metagen Therapeutics
MV BioTherapeutics SA
Norgen Biotek Corp.
Novogene Co, Ltd.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Roche Holding AG
Thermo Fisher Scientific Inc.
Vedanta Biosciences.
Viome Life Sciences, Inc.

Table Information

Report Attribute	Details
No. of Pages	181
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 992.4 Million
Forecasted Market Value ( USD ) by 2032	$ 1840 Million
Compound Annual Growth Rate	10.8%
Regions Covered	Global
No. of Companies Mentioned	30

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Cancer Microbiome Sequencing Market Outlook

Scope & Segmentation

Key Takeaways: Strategic Insights for Senior Decision-Makers

Tariff Impact: Navigating Supply-Chain and Operational Constraints

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Human Microbiome Sequencing Services Market - Global Forecast 2025-2030

Microbiome Sequencing Service Market Report 2025

Microbiome Sequencing Services Market - Global Forecast 2026-2032

Microbiome Sequencing Services - Global Strategic Business Report

Microbiome Diagnostics - Global Strategic Business Report